Figure 6. Activation and expression of signaling proteins were altered in EFNL treatment. Western blot analysis of cell proliferation, cell cycle, and apoptosis signaling proteins revealed reduced phosphorylation of AKT, decreased expression of CDK2, cyclinD1, and BCL2 in the EFNL-treated group. Representative blots were shown with their corresponding densitometric values normalized with internal control β actin.